Clinical Scorecard: Fast Forward to the Future: Contact Lens Microfluidics
At a Glance
Category
Detail
Condition
Visual optical abnormalities and ocular health monitoring
Key Mechanisms
Microfluidics-enabled contact lenses for sensing, fluid control, and drug delivery
Target Population
Contact lens wearers requiring vision correction and ocular health monitoring
Care Setting
Ophthalmic and optometric clinical settings
Key Highlights
Modern contact lenses correct refractive errors, presbyopia, and irregular corneas with potential for higher-order aberration correction.
Microfluidic contact lenses can monitor ocular parameters such as intraocular pressure, tear moisture, proteins, glucose, electrolytes, pH, and lactate.
Future contact lenses may combine diagnostic sensing with drug delivery via microchannels, enabling continuous tear interaction and multifunctionality.
Guideline-Based Recommendations
Diagnosis
Consider contact lenses with integrated sensors for monitoring intraocular pressure and biochemical markers in tears.
Management
Explore drug-eluting contact lenses for targeted ocular therapy, such as ocular allergy treatment, although not yet widely available.
Utilize microfluidic technology in contact lenses to enable precise drug delivery and real-time ocular condition management.
Monitoring & Follow-up
Leverage microfluidic contact lenses for continuous on-eye monitoring of ocular parameters to enhance disease detection and management.
Risks
Current microfluidic and drug-eluting contact lenses are in developmental stages; clinical availability and safety profiles require further validation.
Patient & Prescribing Data
Patients requiring vision correction and those at risk for ocular conditions needing monitoring or drug delivery.
Emerging microfluidic contact lenses may provide combined diagnostic and therapeutic functions, improving personalized ocular care.
Clinical Best Practices
Stay informed on advances in microfluidic contact lens technology for potential future clinical applications.
Educate patients on the evolving role of contact lenses beyond vision correction, including diagnostic and therapeutic potentials.
Monitor ongoing research and regulatory approvals before prescribing drug-eluting or sensor-integrated contact lenses.
In this year’s keynote speech, Craig Norman and Patrick Caroline took a walk down memory lane to examine the last 2 and a half decades of both the Global Specialty Lens Symposium and specialty contact lenses.
